Sanofi rules out Toujeo discount in diabetes
April 14, 2015Sales and Marketing 100 U/mL, Boehringer, Lantus, insulin glargine [rDNA origin] injection, lilly, toujeo
Sanofi has revealed that it will not discount its new insulin Toujeo more than its current blockbuster Lantus, despite lacking …
US drug spend soars to all-time high in 2014
April 14, 2015Manufacturing and Production, Sales and Marketing Lipitor, Obama, UK Health and Social Care Information Centre, US, drug spend, prescribing
The number of prescriptions dispensed in the US rose by 13% in 2014 a new report has shown. The increase …
Manufacturing woes hit Baxter again
April 14, 2015Manufacturing and Production, Sales and Marketing FDA, Gemünden, Pfizer, alesse, baxter, manufacturing, recall, vectura group
Baxter is voluntarily recalling several lots of intravenous solutions due to the potential presence of particulate matter. The news has …
Ashfield Healthcare names new UK managing director
April 14, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ashfield, colin watson
Ashfield Healthcare has appointed Colin Watson as its managing director for the UK, taking over from Enda Scott who has …
Cancer Research Technology and Medivir to develop new class of cancer drugs
April 13, 2015Research and Development, Sales and Marketing Medivir, UK, adam8, cancer research technology, oncology
Cancer Research Technology and Medivir will join forces to develop a new class of drugs that has shown promise for …
Most anticipated health wearable lands shortly
April 13, 2015Medical Communications, Sales and Marketing Apple, digital, research kit, smartwatch, watch, wearable, wearables
Consumers can order Apple’s eagerly anticipated watch now as the industry waits to see just what impact it could have …
Novartis to highlight Gilenya data at neurology congress
April 13, 2015Sales and Marketing American Academy of Neurology, Novartis, fingolimod, gilenya
Novartis will be highlighting data for its multiple sclerosis drug Gilenya at this year’s American Academy of Neurology (AAN) annual …
Drug development showcasing at AACR conference
April 13, 2015Research and Development, Sales and Marketing American Association of Cancer Research, AstraZeneca, Bayer, Genentech, Novartis, aacr
This month’s American Association of Cancer Research conference is set to showcase the latest studies in oncology. Roche’s biotech subsidiary …
AstraZeneca diabetes drug could ‘significantly’ increase mortality
April 13, 2015Research and Development, Sales and Marketing AstraZeneca, FDA, Nesina, Onglyza, Takeda, alogliptin, cardiovascular, saxagliptin
AstraZeneca’s diabetes drug Onglyza may lead to a ‘significant increase’ in risk of death according to a new analysis from …
E-clinical: the rise of new health technologies
April 13, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, NHS, apps, digital, eHealth, eyeforpharma, kelsey, pharma, wearables
In the UK the NHS is generally considered to be traditionally resistant to new technology, but it has been forced …
Bioinformatics pioneer joins 23andMe from Genentech
April 13, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 23andME, Genentech, Robert Gentleman
California-based personal genetics firm 23andMe has appointed Robert Gentleman to be its vice president of computational biology. The company is …
Novo Nordisk opens insulin plant in Russia
April 10, 2015Manufacturing and Production, Sales and Marketing Novo Nordisk, Russia, diabetes, flexpen, insulin, kaluga, penfill
Denmark’s Novo Nordisk has opened a new manufacturing facility in Russia to produce more of its diabetes offerings in the …
Pfizer launches cardiovascular research competition
April 10, 2015Research and Development, Sales and Marketing Amgen, Astellas, LDL, PCSK9, Pfizer, bococizumab, inhibitors
Pfizer is funding a new competitive grants programme to support research projects in the burgeoning, competitive area of cholesterol-lowering PCSK9 …
Eisai cuts 25% of US staff
April 10, 2015Medical Communications, Research and Development, Sales and Marketing Daiichi, Eisai, US, cuts, layoffs, reorganisation, staff
Eisai’s US business is offloading around 200 jobs as part of some restructuring to create a more ‘efficient and focussed …
Shire gets FDA boost – but suffers trial setback
April 10, 2015Research and Development, Sales and Marketing FDA, Shire, algs, lifitegrast, shp625
Shire has achieved mixed results in its attempts to get regulatory approval for two new treatments – bagging a priority …
RSA hires senior consultant
April 10, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kris Richards, rsa
Life sciences executive search and interims specialist firm RSA has appointed a new senior consultant to its executive interims team. …
Over one billion drugs dispensed in England in 2014, NHS report shows
April 9, 2015Sales and Marketing HSCIC, NHS, drug cost, net ingredient cost, prescribing, prescription cost analysis, prescriptions
Patients in England collected over 1.1 billion prescription items in 2014, according to NHS figures. Statistics from the Health and …
Merck and Pfizer to co-promote cancer drug
April 9, 2015Research and Development, Sales and Marketing Cancer, Merck, Merck KGaA, NSCLC, Pfizer, Xalkori, non-small cell lung cancer, oncology
Merck KgaA and Pfizer have agreed to co-promote the latter’s lung cancer treatment Xalkori, and form a new alliance that …
Former FDA commissioner named as Institute of Medicine foreign secretary
April 9, 2015Manufacturing and Production, Medical Communications, Research and Development Dr Margaret Hamburg, FDA, IOM, Institute of Medicine, Margaret Hamburg
Former commissioner of the US Food and Drug Administration Margaret Hamburg has been appointed as the next foreign secretary of …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
